MX2009012369A - Proceso para preparar un agonista del receptor de adenosina-a2a y sus polimorfos. - Google Patents
Proceso para preparar un agonista del receptor de adenosina-a2a y sus polimorfos.Info
- Publication number
- MX2009012369A MX2009012369A MX2009012369A MX2009012369A MX2009012369A MX 2009012369 A MX2009012369 A MX 2009012369A MX 2009012369 A MX2009012369 A MX 2009012369A MX 2009012369 A MX2009012369 A MX 2009012369A MX 2009012369 A MX2009012369 A MX 2009012369A
- Authority
- MX
- Mexico
- Prior art keywords
- polymorphs
- receptor agonist
- adenosine receptor
- preparing
- isolating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Se describe una síntesis adecuada para la fabricación a gran escala de un agonista del receptor de adenosina-A2A, y también se refiere a sus polimorfos del compuesto, y a métodos para aislar un polimorfo específico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2007/069190 WO2008143667A1 (en) | 2007-05-17 | 2007-05-17 | Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009012369A true MX2009012369A (es) | 2009-12-01 |
Family
ID=38543556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009012369A MX2009012369A (es) | 2007-05-17 | 2007-05-17 | Proceso para preparar un agonista del receptor de adenosina-a2a y sus polimorfos. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP2158208B1 (es) |
JP (1) | JP5349461B2 (es) |
KR (2) | KR20140041965A (es) |
CN (1) | CN101668768B (es) |
AU (1) | AU2007353780B2 (es) |
CA (1) | CA2685589C (es) |
ES (1) | ES2537959T3 (es) |
HK (1) | HK1140771A1 (es) |
IL (1) | IL201856A (es) |
MX (1) | MX2009012369A (es) |
NO (1) | NO341758B1 (es) |
NZ (1) | NZ580940A (es) |
PT (1) | PT2158208E (es) |
WO (1) | WO2008143667A1 (es) |
ZA (1) | ZA200907565B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403567B1 (en) | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
US20020012946A1 (en) | 2000-02-23 | 2002-01-31 | Luiz Belardinelli | Method of identifying partial agonists of the A2A receptor |
US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
US7732595B2 (en) | 2006-02-03 | 2010-06-08 | Gilead Palo Alto, Inc. | Process for preparing an A2A-adenosine receptor agonist and its polymorphs |
CZ308577B6 (cs) * | 2011-08-18 | 2020-12-16 | Farmak, A. S. | Způsob přípravy 2-(4-methoxykarbonylpyrazol-1-yl)adenosinu a 2-(4-ethoxykarbonylpyrazol-1-yl)adenosinu |
CZ304053B6 (cs) | 2011-08-22 | 2013-09-04 | Farmak, A. S. | Zpusob prípravy 2-[4-[(methylamino)karbonyl]-1-H-pyrazol-1-yl]adenosinu monohydrátu |
WO2014022577A1 (en) | 2012-08-01 | 2014-02-06 | Lewis And Clark Pharmaceuticals, Inc. | N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as a2a agonists |
US9822141B2 (en) | 2012-08-01 | 2017-11-21 | Lewis And Clark Pharmaceuticals, Inc. | N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists |
CZ305213B6 (cs) | 2013-04-29 | 2015-06-10 | Farmak, A. S. | Polymorf E 2-[4-[(methylamino)karbonyl]-1H-pyrazol-1-yl]adenosinu a způsob jeho přípravy |
WO2014207758A2 (en) | 2013-05-30 | 2014-12-31 | Biophore India Pharmaceuticals Pvt. Ltd. | Novel polymorph of regadenoson |
CN104744540A (zh) * | 2013-12-26 | 2015-07-01 | 上海紫源制药有限公司 | 一种制备瑞加德松的方法 |
CN105085593A (zh) * | 2014-04-21 | 2015-11-25 | 上海紫源制药有限公司 | 瑞加德松的晶型及其制备方法 |
CN105198950B (zh) * | 2014-06-17 | 2018-10-02 | 上海紫源制药有限公司 | 一种瑞加德松晶型e的制备方法 |
CN105315284A (zh) * | 2014-07-23 | 2016-02-10 | 上海医药工业研究院 | 阿拉格列汀中间体的制备方法 |
WO2016126734A1 (en) | 2015-02-06 | 2016-08-11 | Apicore Us Llc | Process of making regadenoson and novel polymorph thereof |
CN106397442B (zh) * | 2015-07-28 | 2020-03-27 | 国药集团国瑞药业有限公司 | 一种瑞加德松的纯化方法 |
WO2017042837A2 (en) * | 2015-09-11 | 2017-03-16 | Sun Pharmaceutical Industries Limited | Stable crystalline form of regadenoson |
US10392417B2 (en) * | 2016-11-04 | 2019-08-27 | Apicore Us Llc | Polymorph of regadenoson and process for preparation thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
NZ538590A (en) * | 2002-08-15 | 2006-10-27 | Cv Therapeutics Inc | Partial and full agonists of A1 adenosine receptors |
EP1883646A1 (en) * | 2005-05-19 | 2008-02-06 | Cv Therapeutics, Inc. | A1 adenosine receptor agonists |
US7732595B2 (en) * | 2006-02-03 | 2010-06-08 | Gilead Palo Alto, Inc. | Process for preparing an A2A-adenosine receptor agonist and its polymorphs |
-
2007
- 2007-05-17 KR KR1020147007723A patent/KR20140041965A/ko not_active Application Discontinuation
- 2007-05-17 MX MX2009012369A patent/MX2009012369A/es active IP Right Grant
- 2007-05-17 KR KR1020097026178A patent/KR101464794B1/ko active IP Right Grant
- 2007-05-17 EP EP07783900.9A patent/EP2158208B1/en active Active
- 2007-05-17 WO PCT/US2007/069190 patent/WO2008143667A1/en active Application Filing
- 2007-05-17 JP JP2010508354A patent/JP5349461B2/ja active Active
- 2007-05-17 NZ NZ580940A patent/NZ580940A/en unknown
- 2007-05-17 ES ES07783900.9T patent/ES2537959T3/es active Active
- 2007-05-17 CN CN2007800529263A patent/CN101668768B/zh active Active
- 2007-05-17 PT PT77839009T patent/PT2158208E/pt unknown
- 2007-05-17 AU AU2007353780A patent/AU2007353780B2/en active Active
- 2007-05-17 CA CA2685589A patent/CA2685589C/en active Active
-
2009
- 2009-10-28 ZA ZA2009/07565A patent/ZA200907565B/en unknown
- 2009-11-01 IL IL201856A patent/IL201856A/en active IP Right Grant
- 2009-12-16 NO NO20093543A patent/NO341758B1/no unknown
-
2010
- 2010-07-27 HK HK10107188.5A patent/HK1140771A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2685589C (en) | 2014-09-16 |
ZA200907565B (en) | 2011-10-26 |
NZ580940A (en) | 2012-02-24 |
JP2010527351A (ja) | 2010-08-12 |
HK1140771A1 (en) | 2010-10-22 |
KR20140041965A (ko) | 2014-04-04 |
ES2537959T3 (es) | 2015-06-16 |
ES2537959T8 (es) | 2016-08-19 |
CN101668768B (zh) | 2012-08-29 |
NO20093543L (no) | 2009-12-16 |
AU2007353780B2 (en) | 2013-11-14 |
PT2158208E (pt) | 2015-06-11 |
KR101464794B1 (ko) | 2014-11-27 |
NO341758B1 (no) | 2018-01-15 |
JP5349461B2 (ja) | 2013-11-20 |
WO2008143667A1 (en) | 2008-11-27 |
EP2158208A1 (en) | 2010-03-03 |
EP2158208B1 (en) | 2015-04-08 |
IL201856A0 (en) | 2010-06-16 |
KR20100021462A (ko) | 2010-02-24 |
IL201856A (en) | 2013-07-31 |
AU2007353780A1 (en) | 2008-11-27 |
CA2685589A1 (en) | 2008-11-27 |
CN101668768A (zh) | 2010-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009012369A (es) | Proceso para preparar un agonista del receptor de adenosina-a2a y sus polimorfos. | |
EP2581381A3 (en) | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | |
NZ734535A (en) | Process of producing cycloalkylcarboxamido-indole compounds | |
EA201170618A1 (ru) | Способ получения защищенных производных l-аланина | |
EP4023641A3 (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
MY201120A (en) | Intermediates for use in a process of producing pyrrole compounds | |
TN2011000590A1 (en) | Preparation of nalmefene hydrochloride from naltrexone | |
HK1184432A1 (en) | Process for preparing intermediates of compounds useful as opioid receptor modulators | |
ZA201102510B (en) | Slurry process for synthesis of biophosphites | |
MX2009013016A (es) | Un procedimiento para preparar compuestos de aminodiol oxazolina-protegidos utiles como intermediarios para florfenicol. | |
TW201206878A (en) | A method of producing ingenol-3-angelate | |
WO2010099441A3 (en) | Synthesis of molecular sieve ssz-74 using a hydroxide-mediated gel | |
GEP20125512B (en) | Process for synthesis of agomelatin | |
MY152281A (en) | 4-pyrimidinesulfamide derivative | |
EG26900A (en) | A process for synthesis of methanol | |
PL2279175T3 (pl) | Sposób wytwarzania związków pośrednich naftalen-2-ylopirazol-3-onu użytecznych w syntezie inhibitorów receptorów sigma | |
IL219274A0 (en) | Process for synthesis of intermediates useful for making substituted indazole and azindazole compounds | |
UA106988C2 (uk) | Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та необхідні проміжні сполуки магнію | |
MX347218B (es) | Metodos para producir sales de viloxazina y polimorfos novedosos de las mismas. | |
GEP20115344B (en) | New process for synthesis of agomelatine | |
GB2482826A (en) | Synthesis of morphine and related derivatives | |
EP2351815A4 (en) | HYDROCARBON SYNTHESIS REACTOR, HYDROCARBON SYNTHESIS REACTION SYSTEM, AND HYDROCARBON SYNTHESIS METHOD | |
MY165659A (en) | Novel method of preparing benzoimidazole derivatives | |
JO2812B1 (en) | A method of obtaining the aggregate V crystal form of agomelatine | |
MX2012003994A (es) | Radiosintesis automatizada. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: GILEAD SCIENCES, INC. |
|
HC | Change of company name or juridical status |
Owner name: GILEAD SCIENCES, INC. |
|
FG | Grant or registration |